Arrow
Arrow
Liv Doctors
Arrow
Prof. MD. Pervin İşeri
Prof. MD. Pervin İşeri
Prof. MD.

Pervin İşeri

Liv Hospital Ulus
Neurology
Areas of Interests
    • Movement Disorders (Parkinson's disease, essential tremor, chorea, tics, myclonia, dystonias)
    • Cognitive Disorders (Alzheimer's and other dementias)
    • Botulinum toxin applications in movement disorders
    • Dizziness and balance disorders
    • Headache
Resume
Publications
Memberships
Courses Attended
 
Experience
  • Kocaeli University Faculty of Medicine, Department of Neurology faculty member
  • Atlas University Faculty of Medicine, Department of Neurology
  • Yeni Yüzyıl University Faculty of Medicine, Department of Neurology faculty member
Administrative Duties:
  • Term 5 coordinator. Kocaeli University Faculty of Medicine, 2004-2008.
  • Clinical Research Unit board member, Kocaeli University Faculty of Medicine, 2009-2011.
  • Asst. Assoc. Appointment preliminary evaluation board membership, Kocaeli University Faculty of Medicine, 2009-2011.
  • Kocaeli University Faculty of Medicine Department of Neurology, 2014
  • Kocaeli University Scientific Research Projects Commission membership, 2014 – 2019
  • Kocaeli University School of Health Directorate, 2014 –2016
  • Atlas University BAP commission chairman
  • Atlas University ethics committee membership
  • Term 5 coordinator. Kocaeli University Faculty of Medicine, 2004-2008.
  • Clinical Research Unit board member, Kocaeli University Faculty of Medicine, 2009-2011.
  • Asst. Assoc. Appointment preliminary evaluation board membership, Kocaeli University Faculty of Medicine, 2009-2011.
  • Kocaeli University Faculty of Medicine Department of Neurology, 2014
  • Kocaeli University Scientific Research Projects Commission membership, 2014 – 2019
  • Kocaeli University School of Health Directorate, 2014 –2016
  • Atlas University BAP commission chairman
  • Atlas University ethics committee membership
 

Research:

  • Tübitak-SBAG-110S387, Isolation and characterization of parkin protein in serum and examination of its relationship with early-onset Parkinson's disease (2011-2013, (Completed).
  • The effect of memantine in harmaline-induced tremor and neurodegeneration. With support from Lundbeck Clinical research department, Denmark. Project Manager, 2005-2009.
  • Postural control system. Tübitak AGY 1003 project. Project Consultancy. 2013.

Clinical Studies:

  • Efficacy of rivastigmine in Parkinson's Disease dementia. Phase IV multicenter clinical trial
  • A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease. Phase III clinical trial
  • CREAD 2: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD). A phase III clinical trial.

A. Articles published in international peer-reviewed journals (SCI/SCI Expanded/Pubmed):

A1. Budak, F., B. Bamaç, A. Özbek, P. Kutluay ve  S. Komsuoğlu, “Nerve conduction studies of lower extremities in pes planus subjects,” Electromyogr. Clin. Neurophysiology, 41(7), 443-6 (2001).
A2. Çiftçi, E., H. Efendi,  M. Kanko ve P. Kutluay, “Acute occlusion of internal carotid artery: thrombolysis and stent placement,” Neurology India, 52(4), 516-7 (2004).
A3. Selekler, H.M., S. Erdoğan, P. İşeri ve S. Komsuoğlu, “The sociodemographic findings, beliefs and behaviours of the patients admitted to Kocaeli University, Faculty of Medicine, Epilepsy Section,” Seizure, 13(6), 438-40 (2004).
A4. İşeri, P.K., D. Bayramgürler ve K. Koç,  “Unilateral localized hyperhidrosis associated with frontal lobe meningioma,” Neurology, 63(9), 1753-4 (2004).
A5. İşeri, P., G. Akansel ve  F. Budak, “Magnetic resonance imaging findings in a patient with bilateral limbic encephalitis,” Archives of Neurology,  62(6),1014-5 (2005).
A6. İşeri, P., O. Altıntaş, T. Tokay ve N. Yüksel, “Correlation between retinal morphological and functional findings and cognitive impairment in Alzheimer’s disease,” Journal of Neuro-ophthalmology 26(1), 18-24, 2006
A7. İşeri, P., H. Efendi, A. Demirci ve S. Komsuoğlu, “Fibrous dysplasia of the cranial bones: a case report and review of the literature,” Yale journal of  Medicine and Biology, 78(3), 141-145, (2005).
A8. İşeri, P., E. Ökten ve T. Aker, “Posttraumatic Stress Disorder (PTSD) and Major Depression (MDD) in Parents of Children with Epilepsy,” Epilepsy and Behavior, 8(1), 250-5 (2006).
A9. Alemdar, M., P. İşeri, H.M. Selekler, A.S. Serbest ve S.S. Komsuoğlu, “Isolated abducens nevre associated with retinoic acid therapy:A case report,” Strabismus,13(3),129-32, (2005).
A10. Alemdar M, Iseri P, Kamacı S, Efendi H, Budak F, Komsuoğlu SS. Risk factors and seasenal diurnal variations in lacunar infarction. Journal of Neurological Sciences (Turkish) 2006;23(2):124:128
A11. Karakaya, I., A. Coşkun, B. Ağaoğlu, P. İşeri, M. İnanır ve H. Canatay, “Psychiatric approach in the treatment of reflex sympathetic dsytrophy in an adolescent girl: A case report,” The Turkish Journal of Pediatrics 48(4), 369-72, (2006).
A12. Alemdar, M., M. Selekler, P. işeri, A. Demirci ve S. Komsuoğlu, “ The importance of EEG and variablity of MRI findings in acute hemorrhagic leukoencephalitis,” European Journal of Neurology 13(11), 1-3, (2006).
A13. İşeri, P., G. Akansel, H. Efendi ve F. Budak, “Acute encephalopathy of plasticizer intoxication: MRI findings of two cases and the review of the literature”. Rivista di Neuroradiologia, 19 (2),216-220, (2006).
A14. Alemdar M, Iseri P, Selekler M, Budak F, Demirci A, Komsuoglu SS MELAS presented with status epilepticus and Anton-Babinski syndrome; value of ADC mapping in MELAS", , J Neuropsychiatry Clin Neurosci, 19(4), 482-3, 2007
A15. Alemdar M, Iseri P, Selekler M, Komsuoğlu SS. Levetiracetam-responding paroxysmal nonkinesigenic dyskinesia.",., Clin Neuropharmacol, 30(4), 241-4, 2007
A16. Anik Y, Iseri P, Demirci A, Komsuoglu S, Inan N. Magnetization transfer ratio in early period of Parkinson disease.  Acad Radiol, 14(2), 189-92, 2007
A17. Alemdar M, Iseri P, Yalug I, Kutlu H, Efendi H, Komsuoglu SS. Route learning impairment associated with encephalomalasia secondary to traumatic brain injury: a case report. Appl Neuropsychol, 15(2), 150-5, 2008.
A18. Altintaş O, Işeri P, Ozkan B, Cağlar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol, 116(2), 137-46, 2008
A19. Alemdar M, Selek A, Işeri P, Efendi H, Komsuoğlu SS. Fahr's disease presenting with paroxysmal non-kinesigenic dyskinesia: a case report.",  Parkinsonism Relat Disord, 14(1), 69-71, 2008
A20. Altıntaş O, İşeri P, Bayramgürler D, Kıran R. Correlation between  VEP and OCT measurements of optic nerve head in Behçet’s disease,” Journal of Neuro-ophthalmology 24(1), 45-51, 2010
A21. Kutlu A, Işeri P, Selekler M, Benbir G, Karadeniz D.
Cyclic alternating pattern analysis in REM sleep behavior disorder.
Sleep Breath. 2013 Mar;17(1):209-15. 
A22. Kozdağ G, Yaymacı M, Işeri P, Ertaş G, Emre E, Bildirici U, Kılıç T, Ural D.
Ischemic stroke history predicts increased cardiovascular mortality in chronic heart failure.
Anadolu Kardiyol Derg. 2011 Aug;11(5):421-7. 
A23. Akman O, Kokturk S, Yardýmoglu M, Erturk S, Ates N. The effect of memantine in harmaline-induced tremor and neurodegeneration.
Neuropharmacology. 2011 Sep;61(4):715-23. 
A24. İseri PK, Altun N, Akansel G. Homonymous quadrantanopia secondary to Behçet Disease. NeurOphthalmology, 36(1), 6-8, 2012
A25. İseri P, Keskin G, Demir FK, Oran A, Derin S, Erdoğan S, İseri M. Rare cases of facial nerve tumors. Int. Adv. otol 2012;9:(1) 115-121.
A26. Kozdağ G, Işeri P, Gökçe G, Ertaş G, Aygün F, Kutlu A, Hebert K, UralD. Treatment with enhanced external counterpulsation improves cognitive functions in chronic heart failure patients. Turk Kardiyol Dern Ars. 2013 Jul;41(5):418-28. 
A27. Işeri P, Başyiğit I, Ozerdem C, Başyiğit H, Efendi H, Yıldız F.
The effect of pulse methylprednisolone plus theophylline treatment on clinical, pulmonary and inflammatory markers in relapses of multiple sclerosis.Balkan Med J. 2013 Mar;30(1):33-6.
A28. Topdag M, Iseri M, Topdag DO, Kokturk S, Ozturk M, Iseri P.
The effect of etanercept and methylprednisolone on functional recovery of the facial nerve after crush injury. Otol Neurotol. 2014 Aug;35(7):1277-83. 
A29. Ozgul S, Kasap M, Akpinar G, Kanli A, Güzel N, Karaosmanoglu K, Baykal AT, Iseri P. Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches.
Neurochem Int. 2015 Jun-Jul;85-86:1-13. 
A30. Alemdar M, Iseri P, Komsuoglu S. Insulinoma in the differential diagnosis of seizure Disorder. The journal of Neuropsychiatry and clinical Neurosciences. 2006;18:247-248.  
A31. Arica-Polat BS, Gündoğdu AA, Cinar N, Uncu G, Ayas ZO, Iseri P, Karadas O, Adapinar DO. Evaluation of cognitive deficits in patients infected with COVID-19. Eur Rev Med Pharmacol Sci. 2022 Jan;26(2):678-685. doi: 10.26355/eurrev_202201_27894.
PMID: 35113443
A32. Hakan Çavuş, Pervin İşeri. Clinical corrrelation of MRI-tractogarphy findings in Hemifacial spasm patients whp are injected botulinum neurotoxin. Neurology India, Kabul, 2021

B.Articles Published in National Journals

B1. Budak, F., H. Efendi, S. Orhan, P. Kutluay and S. Komsuoğlu, “The Effect of Botulismus Toxin Treatment on Clinical and Electrophysiological Findings in Blepharospasm”, Journal of Parkinson's Disease and Movement Disorders, 2(2), 23-26 (1999). ).
B2. İşeri, M., G. Keskin, Ö. Akdeniz, H. Özkarakaş and P. Kutluay, “Modified Epley Maneuver in Benign Paroxysmal Positional Vertigo”, ENT Specialized Journal, 6 (1), 50-54 (1999).
B3. İşeri, M., G. Keskin, P.İ. Kutluay, E. Üstündağ and F. Budak, “Videostroboscopic Evaluation and Acoustic Analysis in Parkinson's Patients”, Parkinson's Disease. Journal of Movement Disorders, 3(2), 29-32 (2000).
B4. Kutluay, P., H. Efendi, F. Budak and S. Komsuoğlu, “A Case with Recurrent Intracerebral Hemorrhage”, Turkish Journal of Neurology, 8(2),75-78 (2002).
B5. İşeri, P., H. Efendi and S. Komsuoğlu, “Bilateral Cerebellar Calcification”, Turkish Journal of Neurology, 8(4), 103-107 (2002).
B6. Kutluay, P., H. Efendi, G. Aybar and S. Komsuoğlu, “Cerebral Venous Thrombosis Due to Homocystinemia”, Turkish Journal of Neurology, 8(4), 99-101, (2002).
B7. İşeri, P. and S. Komsuoğlu, “Apolipoprotein E, Serum Cholesterol Levels and the Role of Statin Group Drugs in Alzheimer's Disease”, Folia, 3(1), 10-12 (2003).
B8. Efendi, H., P. İşeri, G. Karabaş and T. Tokay, “Global Aphasia Without Hemiparesis; Clinical and MRI Findings”, Anadolu Medical Journal, 5(3), 197-200 (2003).
B9. Selekler, M. and P. İşeri, “Increased Muscle Contraction and Relaxation Difficulty in Chronic Headaches”, Neuropsychiatry Archives, 40(3-4), 85-90 (2003).
B10. İşeri, P. and H. Efendi, “Clinical Approach and Treatment to the Dementia Patient”, Sted, 12(12), 458-62 (2003).
B11. Iseri, P.K. and H. Efendi, “Efficacy and Safety of Donepezil and Rivastigmine in Alzheimer's Disease”, Geriatrics, 6(4), 119-123 (2003).
B12. İşeri, P. and F. Budak, “Unusual Thoracic Outlet Syndrome Secondary to Bullet Lodge in Brachial Plexus”, Journal of Neurological Sci. (Turkish), 21(1), 33-36 (2004).
B13. Efendi, H., P. İşeri, G. Karabaş and T. Tokay, “Wilson's Disease with Atypical Clinical Course”, Anadolu Medical Journal, 6 (6), 27-30 (2004).
B14. İşeri, M. and P. İşeri, “Rare Anatomical Variation of the Accessory Nerve”, Journal of Ear Nose and Throat Clinics, Kabul (12.04.2004).
B15. Efendi, H., P. İşeri, T. Tokay, Y. Yıldız, R. Apaydın and C. Erçin, “Raynaud Phenomenon and Increased Level of Anticardiolipin Antibodies in a Patient with Sneddon Syndrome”, Turkish Journal of Neurology, 10(3), 238- 241 (2004).
B16. İşeri, P. and S. Komsuoğlu, “Difficulties Encountered in the Diagnosis of Epilepsy”, Clinical Sciences and Doctors, 10(6), 631-636 (2004).
B17. İşeri, M. and P. İşeri, “Treatment of Unilateral Masseter Hypertrophy with Botulinum Toxin in Two Cases”, Otolaryngology Ihtis Derg. 12(3-4), 99-102 (2004).
B18. İşeri, P. and M. Selekler, “Neuroleptic Malignant Syndrome” Türkiye Hastanesi, 1(5), 39-42, (2005).
B19. İşeri, P., C.I. Yavuz and O. Hamzaoğlu, “Sociodemographic Findings and Care Giving Facilities of Patients Admitted to Kocaeli University, College of Medicine, Dementia Section”, Turkish Journal of Geriatrics (Turkish J. Geritr) 2006.
B20. Alemdar M, Iseri P, Kamacı Ş, Efendi H, Budak F, Komuoğlu S. Risk factors in patients with lacunar cerebral infarction. Journal of Neurological Sciences. 2006; 23(2):7;124-128.
B21. Işeri P, Komsuoğlu İ. Medical treatment of Parkinson's Disease. Türkiye Clinics Neurology Parkinson's Disease Special Issue. Volume:5; 4, 2012.
B22. İşeri P, Komsuoğlu S. Thymoma and its relationship with neurological diseases. Turkish Thoracic Society Thoracic Surgery Bulletin, 3:1; 2012.
B23. Pervin İseri, Demet Güçlüyener. Current Treatments for Alzheimer's Disease. Compilation, Türkiye Clinics 2021
B24. Pervin İseri, Demet Güçlüyener. Parkinson plus Syndromes, Copticobasal degeneration, Review, Türkiye Clinics 2021
B25.Pervin İşeri. Covid-19 pandemic: Effect on Movement Disorders. Türkiye clinics, Compilation 2021

 

  •  
  • President of the Neurodegenerative Diseases Association
  • Turkish Neurology Association
  • Full member of the European Neurological Association
  • Turkish Parkinson Association
  • Kocaeli Alzheimer Association Advisory Board
  • Turkish Alzheimer's Association Eskişehir Branch Member
  • Kocaeli Medical Chamber
  • Member of the Turkish Neurology Association Behavioral Neurology Working Group
  • Member of the Turkish Neurological Association Movement Disorders Working Group
  • Deputy editor of Turkish Journal of Neurology
  • Geri bildirim gönder
  • Yan paneller
  • Geçmiş
  • Kaydedilenler
  • Katkıda bulunun
  •  
  • Good clinical practice certificate (Good Clinical Practice)
  • Occupational physician trainer certificate
  • Electrophysiology subspecialty
  • Neurocognitive evaluation certificate (Certificate of neurocognitive evaluation-Karolinska institute)
Ask our Experts!
You can contact with our experts for your questions!